135 STAT. 411 PUBLIC LAW 117–53—NOV. 10, 2021 Public Law 117–53 117th Congress An Act To amend the Controlled Substances Act to provide for the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances or list I chemicals, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ‘‘Ensuring Compliance Against Drug Diversion Act of 2021’’. SEC. 2. MODIFICATION, TRANSFER, AND TERMINATION OF REGISTRA- TION TO MANUFACTURE, DISTRIBUTE, OR DISPENSE CON- TROLLED SUBSTANCES. Subsection (a) of section 302 of the Controlled Substances Act (21 U.S.C. 822) is amended by adding at the end the following new paragraph: ‘‘(3)(A) Except as provided in subparagraph (C), the registration of any registrant under this title to manufacture, distribute, or dispense controlled substances or list I chemicals terminates if and when such registrant— ‘‘(i) dies; ‘‘(ii) ceases legal existence; ‘‘(iii) discontinues business or professional practice; or ‘‘(iv) surrenders such registration. ‘‘(B) In the case of such a registrant who ceases legal existence or discontinues business or professional practice, such registrant shall promptly notify the Attorney General in writing of such fact. ‘‘(C) No registration under this title to manufacture, distribute, or dispense controlled substances or list I chemicals, and no authority conferred thereby, may be assigned or otherwise trans- ferred except upon such conditions as the Attorney General may specify and then only pursuant to written consent. A registrant to whom a registration is assigned or transferred pursuant to the preceding sentence may not manufacture, distribute, or dispense controlled substances or list I chemicals pursuant to such registra- tion until the Attorney General receives such written consent. ‘‘(D) In the case of a registrant under this title to manufacture, distribute, or dispense controlled substances or list I chemicals desiring to discontinue business or professional practice altogether or with respect to controlled substances and list I chemicals (without assigning or transferring such business or professional practice to another entity), such registrant shall return to the Attorney General for cancellation— ‘‘(i) the registrant’s certificate of registration; Notification. Ensuring Compliance Against Drug Diversion Act of 2021. 21 USC 801 note. Nov. 10, 2021 [H.R. 1899] VerDate Sep 11 2014 13:38 Nov 10, 2021 Jkt 029139 PO 00053 Frm 00001 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL053.117 PUBL053 dkrause on LAP5T8D0R2PROD with PUBLAWS 135 STAT. 412 PUBLIC LAW 117–53—NOV. 10, 2021 LEGISLATIVE HISTORY—H.R. 1899: CONGRESSIONAL RECORD, Vol. 167 (2021): Apr. 14, 15, considered and passed House. Oct. 26, considered and passed Senate. Æ ‘‘(ii) any unexecuted order forms in the registrant’s posses- sion; and ‘‘(iii) any other documentation that the Attorney General may require.’’. SEC. 3. DETERMINATION OF BUDGETARY EFFECTS. The budgetary effects of this Act, for the purpose of complying with the Statutory Pay-As-You-Go Act of 2010, shall be determined by reference to the latest statement titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this Act, submitted for printing in the Congressional Record by the Chairman of the House Budget Com- mittee, provided that such statement has been submitted prior to the vote on passage. Approved November 10, 2021. VerDate Sep 11 2014 13:38 Nov 10, 2021 Jkt 029139 PO 00053 Frm 00002 Fmt 6580 Sfmt 6580 E:\PUBLAW\PUBL053.117 PUBL053 dkrause on LAP5T8D0R2PROD with PUBLAWS